For past Congresses, use the Browse menu.
HR 6155
116th Congress • 2019–2021 (Ended)

To amend the Biologics Price Competition and Innovation Act of 2009 to make improvements with respect to the transition of biological products, and for other purposes.


Organizations below reported lobbying activity on this bill. Expand to view filing details.
Loading filings…